Furthermore, the proposed inflammation-GHRL/MSTN-appetite improvement/muscle growth-CHF improvement pathway offers a potential regulatory mechanism,which represents a promising direction for research into the mechanisms of malnutrition and muscle loss disorders in patients with CHF. This evidence concerns the gene MSTN and malnutrition.